{
    "2018-04-27": [
        [
            {
                "time": "",
                "orginal_text": "国际医药巨头即将登陆A股 药明康德引领国内CRO风潮",
                "features": {
                    "keywords": [
                        "药明康德",
                        "CRO",
                        "A股",
                        "医药巨头"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CRO行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "药明康德顶格申购需配市值31万 一签或至少获利4万 挣钱效应凸显",
                "features": {
                    "keywords": [
                        "药明康德",
                        "申购",
                        "市值",
                        "获利"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "资本市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "药研独角兽药明康德的过人之处",
                "features": {
                    "keywords": [
                        "药明康德",
                        "独角兽",
                        "过人之处"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "研发"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "有鱼有研究 药明康德是如何赋能中国创新？",
                "features": {
                    "keywords": [
                        "药明康德",
                        "赋能",
                        "中国创新"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "创新"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "CRO领军企业药明康德即将登陆A股 CRO行业带来发展契机",
                "features": {
                    "keywords": [
                        "药明康德",
                        "CRO",
                        "A股",
                        "发展契机"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CRO行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "药明康德:CRO龙头回归,医药独角兽浪潮已起",
                "features": {
                    "keywords": [
                        "药明康德",
                        "CRO",
                        "龙头",
                        "独角兽"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CRO行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "药明康德新研发基地建成 进一步提升药物研发测试服务能力",
                "features": {
                    "keywords": [
                        "药明康德",
                        "研发基地",
                        "服务能力"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "研发"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}